ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

TXNIP contributes to bone loss via promoting the mitochondrial oxidative phosphorylation during glucocorticoid-induced osteoporosis

Mo, Yulin; Lai, Wenxiu; Zhong, Ying; Hu, Zhuoqing; You, Meigui; Du, Minqun; Wang, Pan; Wu, Xinyou; Chen, Cailing; He, Huanmin; Gao, Zhimin; Xu, Yaping; Wang, Dongtao; Cui, Liao*; Yang, Yajun*广东医学院; 广州医学院; 南方医科大学
Life Sciences2021-2-1DOI: 10.1016/j.lfs.2020.118938
14被引11阅读
引用收藏
分享

摘要

Oxidative stress is a promoting factor in the pathologic process of glucocorticoid - induced osteoporosis (GIO), while the mechanism is still unclear. Thioredoxin-interacting protein (TXNIP) is a vital protein responsible for regulation of cellular reactive oxygen species (ROS) generation elicited by mitochondrial oxidative stress, and which may activate oxidative phosphorylation under the pathogenic status. In this research, the results showed that signaling pathway associated with the mitochondrial oxidative phosphorylation (MOP) down-regulated under conditions of TXNIP siRNA in MG63 cells. Furthermore, the evidence revealed that the expression level of TXNIP in serum and bone was elevated in a rat of GIO. Moreover, the differential proteins (Ndufs3, SDHD, Cyt B, COX IV, and ATP B) related to MOP pathway were identified to down-regulate in the proteomics of bone tissues by using isobaric Tags for Relative and Absolute Quantification (iTRAQ) method in TXNIP knockout mice treated with glucocorticoid, and the proteins were also verified by simple western blot. Taken together, the present findings highlights that TXNIP involves in triggering the process of bone loss via up-regulation of the MOP pathway, resulting to GIO, while TXNIP knockout can prevent the pathogenesis of GIO to some extent.

学科与关键词

关键词
TXNIPGlucocorticoid-induced osteoporosisMitochondrial oxidative phosphorylationBone lossProteomics
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Life Sciences
发表日期
2021-02-01
卷期
第 266 卷
页码
118938
DOI
10.1016/j.lfs.2020.118938
语言
ENGLISH
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81673814]; Science and Technology Planning Project of Guangdong Province of China [2016A020215148, 2016B030309002]; Medical Scientific Research Foundation of Guangdong Province of China [A2016293]; Key laboratory of functional and clinical translational medicine, Fujian province university [JNYLC1812]

作者

  • M

    Mo, Yulin (第一作者)

    guangdong med univ · guangxi univ chinese med

  • L

    Lai, Wenxiu

    guangdong med univ

查看全部 15 位作者收起作者
  • Z

    Zhong, Ying

    guangdong med univ

  • H

    Hu, Zhuoqing

    2 · guangzhou med univ

  • Y

    You, Meigui

    xiamen med coll

  • D

    Du, Minqun

    guangdong med univ

  • W

    Wang, Pan

    guangdong med univ

  • W

    Wu, Xinyou

    guangdong med univ

  • C

    Chen, Cailing

    guangdong med univ

  • H

    He, Huanmin

    guangxi univ chinese med

  • G

    Gao, Zhimin

    guangxi univ chinese med

  • X

    Xu, Yaping

    xiamen med coll

  • W

    Wang, Dongtao

    southern med univ

  • C

    Cui, Liao (通讯)

    guangdong med univ

  • Y

    Yang, Yajun (通讯)

    guangdong med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417